Bionomics licenses BNC375 for up to $558m
24 June, 2014 by Dylan Bushell-EmblingBionomics (ASX:BNO) has signed a research collaboration and licensing deal with Merck covering BNC375, a treatment candidate for Alzheimer's and other CNS conditions.
Biotech student to showcase research in AbbVie Student Poster Awards
19 June, 2014The AusBiotech 2014 national conference will feature a student poster display in the main exhibition hall for the duration of the conference, and the national winner of the AbbVie Student Poster Awards.
Mesoblast's MPCs show promise in type 2 diabetes
19 June, 2014 by Dylan Bushell-EmblingMesoblast (ASX:MSB) revealed its MPCs were able to improve glycaemic control during a phase II trial in type 2 diabetes.
Osprey gets FDA clearance for second-gen AVERT
17 June, 2014 by Dylan Bushell-EmblingOsprey Medical (ASX:OSP) has secured FDA 510(k) approval for the improved version of its AVERT system, designed to reduce the risk of kidney damage from the dyes used in heart procedures.
Australia needs tax incentives to be globally competitive
17 June, 2014AusBiotech has submitted to the Competition Policy Review (June 2014) that Australia needs to complement the R&D Tax Incentive with the Australian Innovation and Manufacturing (AIM) Incentive if it is to remain competitive and relevant on the world stage.
Ortho-ATI shows promise in hip tendon pain
16 June, 2014 by Dylan Bushell-EmblingOrthocell has presented results of a successful pilot trial of regenerative therapy Ortho-ATI in 12 patients with gluteal tendinopathy.
GI Dynamics presents EndoBarrier research
16 June, 2014 by Dylan Bushell-EmblingGI Dynamics (ASX:GID) has presented more research into the effectiveness of - and mechanism of action behind - EndoBarrier, its non-surgical device therapy for obesity and type 2 diabetes.
Starpharma completes chairman succession
16 June, 2014 by Dylan Bushell-EmblingRob Thomas has formally taken over from Peter Bartels as chairman of Starpharma (ASX:SPL) following a seven-month transition period.
AsureQuality receives certification for medical device
16 June, 2014AsureQuality has recieved certification for the contract manufacture of in vitro diagnostic medical devices.
Phosphagenics employees plead guilty over fraud
13 June, 2014A hearing into the alleged fraud against Phosphagenics has resulted in two men pleading guilty to issuing false invoices worth millions of dollars.
Biotech survey shows advanced manufacturing heading overseas
12 June, 2014The annual Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced manufacturing associated with this industry of the future is following traditional manufacturing and there has been a sharp increase in the number of companies heading overseas.
UWA Professor named WA's Chief Scientist
11 June, 2014 by Dylan Bushell-EmblingMedical research luminary Professor Peter Klinken has taken the role of Western Australia's Chief Scientist and aims to change the state's research focus from oil and gas mining to biotechnology.
Outcome on employee share schemes expected mid-June
10 June, 2014Treasury has confirmed that issues raised in submissions to its review of 'employee share schemes (ESS) and start-ups' will be considered by the Prime Minister's taskforce established to develop a National Industry Investment and Competitiveness Agenda, which is expected to be delivered in the coming weeks.
First burns patient treated in NovoSorb BTM trial
06 June, 2014 by Dylan Bushell-EmblingCalzada (ASX:CZD) revealed that the first burns patient enrolled in a clinical trial of its NovoSorb BTM has been successfully treated and is out of intensive care.
Starpharma making progress with clinical trials
06 June, 2014 by Dylan Bushell-EmblingStarpharma (ASX:SPL) has dosed the first group of patients for a phase I trial of DEP docetaxel in solid tumours and commenced final preparations for a phase III trial of VivaGel for the prevention of BV recurrence.
